Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Clinical Trial to Investigate Safety, Tolerability and Efficacy of Dexibuprofen Gebro 400 mg Powder for Oral Suspension (Test) Compared to Ibuprofen 400 mg Powder for Oral Suspension (Reference) in Patients Suffering From Osteoarthritis of the Hip or Knee

NCT01066676 is registered in ClinicalTrials.gov with Gebro Pharma GmbH as lead sponsor.

NCT NCT01066676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01066676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Clinical Trial to Investigate Safety, Tolerability and Efficacy of Dexibuprofen Gebro 400 mg Powder for Oral Suspension (Test) Compared to Ibuprofen 400 mg Powder for Oral Suspension (Reference) in Patients Suffering From Osteoarthritis of the Hip or Knee
Lead sponsor
Gebro Pharma GmbH
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2009
Completion date
June 30, 2012
Enrollment
482 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis of the hip or knee